Niagen Bioscience, Inc. — Form 10-Q
Filed August 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 28/100
What the filing says
ChromaDex, Inc. (tenant) signed a lease with DE Park Avenue 1100, LLC (landlord) for Suite 1800 (10,564 rentable sq ft) at 1100 Glendon Ave, Los Angeles, commencing April 1, 2027, expiring January 31, 2035. Fixed monthly rent escalates from $44,897 (Apr 2027) to $55,218 (Apr 2034). Tenant receives 10 months rent abatement (Apr–Jan 2028) and $211,280 FF&E allowance. Niagen Bioscience, Inc. (parent/guarantor) guarantees all obligations. Tenant's share of operating expenses: 3.03%; security deposit: $65,419.
Why this rating
Routine real estate lease execution. ~$5.4M committed rent over 7.8 years (~0.7% of company market cap) is material but typical operating cost; boilerplate office lease; no strategic change.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.